Literature DB >> 6849727

Influence of urapidil on intracranial pressure and intracranial compliance in dogs.

C Puchstein, H Van Aken, C Anger, J Hidding.   

Abstract

During induced hypotension with urapidil, measurements of intracranial pressure and of the ventricular volume-pressure response (intracranial compliance) were obtained in dogs with and without intracranial hypertension. A bolus of urapidil 50 mg plus an infusion of urapidil 8.2 +/- 1.2 mg min-1 decreased mean arterial pressure by 22 +/- 10% from control in group I (without intracranial hypertension) and by 24 +/- 8% in group II (with intracranial hypertension). In both groups there was no change in intracranial pressure or in intracranial compliance after the administration of urapidil.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849727     DOI: 10.1093/bja/55.5.443

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  2 in total

1.  Influence of urapidil on cerebrospinal fluid pressure in humans with uncompromised intracranial compliance.

Authors:  C Hörmann; G Luz; J Langmayr; S Schalow; A Benzer
Journal:  Intensive Care Med       Date:  1995-10       Impact factor: 17.440

Review 2.  Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H D Langtry; G J Mammen; E M Sorkin
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.